Zomedica (ZOMDF) Research & Development (2017 - 2026)
Zomedica (ZOMDF) recorded Research & Development of $1.2 million in Q3 2026, down 32.5% from $1.78 million a year earlier but up 12.5% from the prior quarter.
Powered by 
Analysis
Zomedica (ZOMDF) Research & Development (2017 - 2026) Analysis & Trends
On a TTM basis, Zomedica's Research & Development came in at $5.07 million as of Sep 30, 2026, down 33.9% year-over-year; for FY2025, it came in at $7.17 million, down 1.4% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $7.27 million in FY2024 (+26.5%), $5.74 million in FY2023 (+122.8%), $2.58 million in FY2022 (+54.1%) and $1.67 million in FY2021 (-79.2%).
- Quarterly Research & Development has ranged from $319,000 in Q2 2022 to $3.1 million in Q4 2023 over the past five years.
- On a year-over-year basis, Research & Development has declined for five consecutive quarters, with an average decline of 17.6% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 347.2% in Q4 2023, against a decline of 43.3% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.07 million (Q2 2026), $1.15 million (Q1 2026) and $1.64 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Zomedica | 97.99 Mn | -87.03 Mn | 6.04 Mn | 1.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.20 Mn |
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.78 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 867,000.00 |
| Jun 30, 2023 | 859,000.00 |
| Mar 31, 2023 | 918,000.00 |
| Dec 31, 2022 | 693,000.00 |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 319,000.00 |
| Mar 31, 2022 | 351,000.00 |
| Dec 31, 2021 | 665,000.00 |
API Access
Zomedica Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ZOMDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ZOMDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();